Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxia and drug resistance

B A Teicher1

  • 1Dana-Farber Cancer Institute, Boston, MA 02115.

Cancer Metastasis Reviews
|June 1, 1994
PubMed
Summary

Hypoxia, or low oxygen, in solid tumors causes therapeutic resistance by altering cell metabolism and increasing genetic instability. Strategies to overcome this include oxygen delivery and using drugs targeting hypoxic cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugate targets.

Current cancer drug targets·2009
Same author

Role of angiogenesis in the response to anticancer therapies.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.

Anticancer research·2002
Same author

Malignant cells, directors of the malignant process: role of transforming growth factor-beta.

Cancer metastasis reviews·2002
Same author

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.

Cancer chemotherapy and pharmacology·2002
Same author

Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2001

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Hypoxia is prevalent in solid tumors and significantly impacts cancer treatment outcomes.
  • Low oxygen conditions directly impair the efficacy of oxygen-dependent therapies like radiation and certain chemotherapies.
  • Hypoxia induces metabolic changes and enhances genetic instability in tumor cells, contributing to drug resistance.

Purpose of the Study:

  • To review the multifaceted effects of tumor hypoxia on anti-cancer agent efficacy.
  • To discuss therapeutic strategies aimed at overcoming hypoxia-induced resistance.
  • To explore the potential of hypoxia-selective agents in cancer treatment.

Main Methods:

  • Literature review of studies investigating hypoxia in solid tumors.
  • Analysis of the impact of hypoxia on cellular metabolism and drug detoxification.
  • Examination of therapeutic approaches to mitigate hypoxia-related resistance.

Main Results:

  • Hypoxia directly reduces the cytotoxicity of oxygen-dependent treatments.
  • Tumor cells under hypoxia exhibit altered metabolism and increased capacity for drug detoxification.
  • Hypoxia promotes genetic instability, accelerating the evolution of resistant cell populations.

Conclusions:

  • Hypoxia is a critical factor driving therapeutic resistance in solid tumors.
  • Strategies involving oxygen delivery and the development of hypoxia-targeted therapies are crucial for improving treatment outcomes.
  • Targeting hypoxic cells directly offers a promising avenue for overcoming treatment resistance.

Related Experiment Videos